AIBT 10-K & 10-Q changes, risk factors and insider trading
Aibotics, Inc. · OTC · Medicinal Chemicals & Botanical Products · CIK 1763329 · All filings on SEC.gov
At a glance
What changed in the latest 10-K
Risk Factors
We are not required to provide the information called for by this item.
No wording changes found in this section.
Full comparison: every changed paragraph (0)
Management's Discussion & Analysis (MD&A)
Largest changes
“The Company’s existence is dependent upon our ability to develop profitable operations. We are devoting substantially all of our efforts to developing the Company’s business and raising capital and there can be no assurance that our efforts will be successful. No assurance can be given that our actions will result in profitable operations or the resolution of its liquidity problems. The accompanying consolidated financial statements do not include any adjustments that might result should the company be unable to continue as a going concern.”see in full comparison
“For the year ended December 31, 2025, the Company incurred a net loss of $2,215,751, had negative cash flows from operations of $458,240 and may incur additional future losses. At December 31, 2025, the Company had total current assets of $270,107 and total current liabilities of $4,834,905, resulting in a working capital deficit of $4,564,798. These conditions raise substantial doubt about the Company’s ability to continue as a going concern for a period of time within one year after that date that the consolidated financial statements are issued.”see in full comparison
“For the year ended December 31, 2024 compared to the year ended December 31, 2023 our interest expense decreased $351,165, or 62%, from $564,623 to $213,458. The decrease primarily resulted from $500,000 less in debt discount amortization from the Company’s convertible notes partially offset by $232,000 of additional interest expense accrued during the third quarter of 2024 due to the default interest on the Company’s convertible note payables in default.”see in full comparison
“Liquidity refers to the Company’s ability to generate sufficient cash to meet its operating and financing obligations. As of December 31, 2025, the Company had cash and cash equivalents of $255,940, compared to $185,097 as of December 31, 2024, representing an increase of $70,843. The change in cash was primarily attributable to cash used in operating activities, partially offset by financing activities during the year. As of December 31, 2025, the Company had approximately $1.1 million of undiscounted obligations related to indebtedness due within one year. …”see in full comparison
“Liquidity is the ability of an enterprise to generate adequate amounts of cash to meet its needs for cash requirements. As of December 31, 2024, we had $185,097 in cash and cash equivalents compared to $279,134 at December 31, 2023, a decrease of $94,037 resulting primarily from cash used in operating expenses. As of December 31, 2024, we had undiscounted obligations in the amount of approximately $1.1 million relating to the payment of indebtedness due within one year.”see in full comparison
see in full comparisonExpensesOperatingfrom operationsexpenses for the years ended December 31,20242025 and2023,2024 consisted solely of general and administrative expenses. General and administrative expensesconsistedprimarilyofinclude consulting fees, board compensation, and legal and professional services.ForGeneral and administrative expenses increased by $212,039, or 13%, to $1,846,856 for the year ended December 31,20242025, compared to $1,634,817 for the year ended December 31,2023 our general and administrative expense increased by $1,018,093 or 165%, from $616,724 to $1,634,817.2024. The increaseinwasgeneralprimarily driven by higher consulting fees of $176,324, increased legal andadministrativeprofessionalexpenses was the resultfees ofincreased$38,072,amortizationand higher advertising and marketing expenses of$607,664,$52,638,increasepartially offset by a decrease in board compensation of$101,250, increase in product development expense of $178,665 and increase in consulting fees of $47,000.$90,000.
Full comparison: every changed paragraph (20)
WeThe didCompany not have anygenerated revenue orof cost$2,183 for the year ended December 31, 2025, compared to no revenue for the year ended December 31, 2024. Cost of revenuesales fromwas operations$0 for both the years ended December 31, 20242025 and 2023.2024.
ExpensesOperating from operationsexpenses for the years ended December 31, 20242025 and 2023,2024 consisted solely of general and administrative expenses. General and administrative expenses consisted primarily ofinclude consulting fees, board compensation, and legal and professional services. ForGeneral and administrative expenses increased by $212,039, or 13%, to $1,846,856 for the year ended December 31, 20242025, compared to $1,634,817 for the year ended December 31, 2023 our general and administrative expense increased by $1,018,093 or 165%, from $616,724 to $1,634,817.2024. The increase inwas generalprimarily driven by higher consulting fees of $176,324, increased legal and administrativeprofessional expenses was the resultfees of increased$38,072, amortizationand higher advertising and marketing expenses of $607,664,$52,638, increasepartially offset by a decrease in board compensation of $101,250, increase in product development expense of $178,665 and increase in consulting fees of $47,000.$90,000.
Other expenseexpenses for the years ended December 31, 20242025 and 20232024 was composedconsisted of interest expense..expense and loss on extinguishment of liabilities.
Interest expense increased by $13,444, or 6%, to $226,902 for the year ended December 31, 2025, compared to $213,458 for the year ended December 31, 2024. The increase was primarily due to an additional $78,418 interest expense incurred during the year, partially offset by the absence of $65,070 of non-cash interest expense recognized in the prior year.
Loss on extinguishment of liabilities was $144,176 for the year ended December 31, 2025, compared to $0 for the year ended December 31, 2024. The increase was primarily attributable to losses recognized on the conversion of liabilities during the current year, whereas no such transactions occurred in the prior year.
For the year ended December 31, 2024 compared to the year ended December 31, 2023 our interest expense decreased $351,165, or 62%, from $564,623 to $213,458. The decrease primarily resulted from $500,000 less in debt discount amortization from the Company’s convertible notes partially offset by $232,000 of additional interest expense accrued during the third quarter of 2024 due to the default interest on the Company’s convertible note payables in default.
Liquidity refers to the Company’s ability to generate sufficient cash to meet its operating and financing obligations. As of December 31, 2025, the Company had cash and cash equivalents of $255,940, compared to $185,097 as of December 31, 2024, representing an increase of $70,843. The change in cash was primarily attributable to cash used in operating activities, partially offset by financing activities during the year. As of December 31, 2025, the Company had approximately $1.1 million of undiscounted obligations related to indebtedness due within one year. The Company expects to meet its short-term liquidity needs through a combination of existing cash on hand and potential additional financing, although there can be no assurance that such financing will be available on acceptable terms, or at all.
Liquidity is the ability of an enterprise to generate adequate amounts of cash to meet its needs for cash requirements. As of December 31, 2024, we had $185,097 in cash and cash equivalents compared to $279,134 at December 31, 2023, a decrease of $94,037 resulting primarily from cash used in operating expenses. As of December 31, 2024, we had undiscounted obligations in the amount of approximately $1.1 million relating to the payment of indebtedness due within one year.
As of December 31, 2024,2025, wethe Company had a working capital deficiency of $4,666,666$4,564,798, downcompared fromto a working capital deficiency of $3,394,768$4,666,666 as of December 31, 2023.2024. At December 31, 2024 our2025, current assets weretotaled $185,097$270,107, and consistedconsisting solely of cash. As of December 31, 2024 our currentCurrent liabilities were $4,851,763$44,834,905 and consisted predominantlyprimarily of accrued interest, convertible notes payable, and shares to be issued. WeThe Company had an accumulated deficit of $13,025,007 as of December 31, 2025, compared to $10,809,256 as of December 31, 2024, anreflecting increasecontinued fromoperating anlosses accumulatedand deficitfinancing-related ofactivities $8,960,981during asthe of December 31, 2023.year.
Our monthly operating costs averaged approximately $22,000 per month for the year ended December 31, 2024, excluding capital expenditures. We did not have capital expenditures during the year ended December 31, 2024. However, we did acquire new intangible assets in exchange for the issuance of preferred shares. We plan to fund our operations with our cash on hand and additional financing.
OperatingNet cash used in operating activities usedwas net$458,240 cashfor ofthe year ended December 31, 2025, compared to $259,037 for the year ended December 31, 2024, as compared to using net cash of $106,765 for the year ended December 31, 2023.2024. For the year ended December 31, 2024,2025, cash used in operating activities was primarily driven by oura net loss of $1,848,275;$2,215,751, partially offset primarily by thenon-cash charges, including amortization expense of $667,332, amortization of debt discounts,discounts of $16,973, and a loss of $144,176 recognized on the increaseissuance of common stock to settle liabilities. Additionally, changes in relatedoperating party accrued expenses,assets and theliabilities increaseprovided $929,030 in accounts payable and accrued expenses.activity.
For the year ended December 31, 2023,2024, cash used in operating activities was primarily driven by oura net loss of $1,181,347;$1,848,275, partially offset primarily by stock-basednon-cash compensation,charges, theincluding amortization of debt discounts,discounts of $9,349, amortization expense of $667,883, and a loss of $79,591 recognized on the increaseissuance of common stock to settle liabilities. Additionally, changes in working capital provided $831,917 of cash, primarily driven by increases in related party accrued expenses and accounts payable and accrued expenses.
Investing activities used net cash of $0 for the year ended December 31, 2025 and 2024.
Net cash provided by financing activities was $529,083 and $165,000 for the years ended December 31, 2025 and 2024, respectively. For the year ended December 31, 2025, financing activities consisted primarily of $300,000 in proceeds from convertible notes payable and $279,083 in proceeds from the issuance of common stock, partially offset by $50,000 in repayments of convertible notes.
Financing activities produced cash flows of $165,000 and $0 for the year ended December 31, 2024, and 2023, respectively. We did not pay any cash for interest or for income taxes during the year ended December 31, 20242025 and 2023.2024.
Going Concern
Our consolidated financial statements have been prepared assuming we will continue as a going concern. Our ability to continue our operations as a going concern is dependent on management’s plans, which includes successfully integrating AIBotics,Aibotics, Inc.Inc., which was acquired subsequent to December 31, 2024.2025. The accompanying consolidated financial statements have been prepared on a going concerngoing-concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. These consolidated financial statements do not include any adjustments relating to the recovery of the recorded assets or the classification of the liabilities that might be necessary should we be unable to continue as a going concern.
For the year ended December 31, 2025, the Company incurred a net loss of $2,215,751, had negative cash flows from operations of $458,240 and may incur additional future losses. At December 31, 2025, the Company had total current assets of $270,107 and total current liabilities of $4,834,905, resulting in a working capital deficit of $4,564,798. These conditions raise substantial doubt about the Company’s ability to continue as a going concern for a period of time within one year after that date that the consolidated financial statements are issued.
The Company’s existence is dependent upon our ability to develop profitable operations. We are devoting substantially all of our efforts to developing the Company’s business and raising capital and there can be no assurance that our efforts will be successful. No assurance can be given that our actions will result in profitable operations or the resolution of its liquidity problems. The accompanying consolidated financial statements do not include any adjustments that might result should the company be unable to continue as a going concern.
The depreciation of equipment and is dependent upon estimates of useful lives and residual values, both of which are determined through the exercise of judgement. The assessment of any impairment of these assets is dependent upon estimates of recoverable amounts that consider factors such as economic/market conditions and the useful lives of assets.
What changed in the latest 10-Q
Risk Factors
We could not find a separate Risk Factors item in the latest 10-Q. Some companies leave it out of quarterly reports; see the annual 10-K risk factors and the original filing. Open the filing on SEC.gov.
Management's Discussion & Analysis (MD&A)
New heading “Six months Ended June 30, 2026 as Compared to the Six months Ended June 30, 2025”
New heading “Sales and Cost of Sales”
New heading “Operating Expenses”
Largest changes
“Six months Ended June 30, 2026 as Compared to the Six months Ended June 30, 2025”see in full comparison
Threesee in full comparisonMonthsmonths EndedMarchJune31,30, 2026 as Compared to theThreethreeMonthsmonths EndedMarchJune31,30, 2025
Operating activities used net cash ofsee in full comparison$36,258$83,280 for thethreesix months endedMarchJune31,30, 2026, as compared to using net cash of$28,360$192,918 for thethreesix months endedMarchJune31,30, 2025. For thethreesix months endedMarchJune31,30, 2026, cash used in operating activities was primarily driven by our net loss of$418,105$955,073; offset primarily by non-cash additions of amortizationexpense,expensetheofincrease$330,593, amortization of debt discount of $11,027, loss on extinguishment of liabilities of $76,388, and issuance of common stock for services of $50,000 and changes inrelatedoperatingparty accrued expenses, the increase in accrued interest,assets and liabilities including the increase in accounts payable and accruedexpenses.expenses of $214,802, the increase in related party accrued expenses of $144,000, the increase in accrued interest $73,008, the decrease in prepaid expenses of $12,500, partially offset by the increase in inventory of $40,525. For thethreesix months endedMarchJune31,30, 2025, cash used in operating activities was primarily driven by our net loss of$591,397$1,077,546; offset primarily by non-cash adjustments for amortizationexpense,expense of approximately $328,000 and the gain recognized on common stock issued to settle liability of approximately $55,000, and changes in operating assets and liabilities including the increase in related party accrued expenses of approximately $94,000, the increase in accrued interest of approximately $60,038, and the increase in accounts payable and accrued expensesandoftheapproximatelyincrease in related party accrued expenses.$344,739.
“Operating expenses for the three months ended March 31, 2026 and 2025, consisted solely of general and administrative expenses. General and administrative expenses consisted primarily of consulting fees, stock-based compensation, board compensation, and legal and professional services. For the three months ended March 31, 2026 compared to the three months ended March 31, 2025 our general and administrative expense decreased by $172,184, or 32%, from $531,647 to $359,463. …”see in full comparison
Full comparison: every changed paragraph (28)
Three Monthsmonths Ended MarchJune 31,30, 2026 as Compared to the Threethree Monthsmonths Ended MarchJune 31,30, 2025
We did not have any revenue andor cost of revenue from operations for the three months ended MarchJune 31,30, 2026, as compared to $2,183 in revenue2026 and cost of revenue from operations for the three months ended March 31, 2025.
Operating expenses for the three months ended June 30, 2026 and 2025 consisted solely of general and administrative expenses. For the three months ended June 30, 2026, general and administrative expenses primarily included amortization expenses of approximately $166,210, board compensation of $48,750, software and web development fees of approximately $56,950, and legal and professional services of approximately $51,861.
For the three months ended June 30, 2026, general and administrative expenses increased by $53,084, or 14.7%, compared to the same period in 2025, increasing from $360,579 to $413,663. The increase was primarily attributable to software development expenses of $56,535, an increase in legal fees of $14,826, increase of board compensation of $8,750, and an increase in marketing of $4,687, partially offset by a decrease in consulting fees of $30,998.
Operating expenses for the three months ended March 31, 2026 and 2025, consisted solely of general and administrative expenses. General and administrative expenses consisted primarily of consulting fees, stock-based compensation, board compensation, and legal and professional services. For the three months ended March 31, 2026 compared to the three months ended March 31, 2025 our general and administrative expense decreased by $172,184, or 32%, from $531,647 to $359,463. The decrease in general and administrative expenses was primarily the result of decreased legal & professional services of $15,138, a decrease in product development expense of $156,372, a decrease in consulting fees of $6,646, a decrease in other business expenses of $4,603, offset by an increase in other general and administrative expenses of $10,575.
Other expense for the three months ended MarchJune 31,30, 2026 and 2025 was composed of interest expense.expense and loss on extinguishment of liabilities.
Other expense for the three months ended June 30, 2026, decreased by $1,765, or 1.4%, compared to the same period in 2025, decreasing from $125,570 to $123,305. The decrease was primarily driven by lower interest expense resulting from the conversion of outstanding debt during 2026, partially offset by higher losses on extinguishment of liabilities recognized in connection with the conversion of debt principal and other payable balances during 2026.
For the three months ended March 31, 2026 compared to the three months ended March 31, 2025 our interest expense decreased by $3,291, or 5%, from $61,933 to $58,642. The decrease was primarily the result in differences in the convertible notes payable we had outstanding during the three months ended March 31, 2026 compared to the three months ended March 31, 2025.
For the three months ended MarchJune 31,30, 2026 and 2025 we had a net loss of $418,105$536,968 and $591,397,$486,149, respectively.
Six months Ended June 30, 2026 as Compared to the Six months Ended June 30, 2025
Sales and Cost of Sales
For the six months ended June 30, 2026, we had revenue and cost of revenue from operations of $0, as compared to $2,183 in revenue and $0 in cost of revenue from operations for the six months ended June 30, 2025.
Operating Expenses
Operating expenses for the six months ended June 30, 2026 and 2025 consisted solely of general and administrative expenses. For the six months ended June 30, 2026, general and administrative expenses primarily included amortization expenses of approximately $330,593, board compensation of $88,750, consulting fees of approximately $166,666, software development expense of approximately $56,950 and legal and professional services of approximately $88,750.
For the six months ended June 30, 2026, general and administrative expenses decreased by $119,010, or 13.3%, compared to the same period in 2025, decreasing from $892,226 to $773,126. The decrease was primarily attributable to a decrease in consulting fees of $37,644, and decrease in product development expenses of $156,372, partially offset by an increase of software development fees of $56,535.
Other Expense
Other expense for the six months ended June 30, 2026 and 2025 was composed of interest expense and loss on extinguishment of liabilities.
Other expense for the six months ended June 30, 2026 decreased by $5,556 or 3.0%, compared to the same period in 2025, decreasing from $187,503 to $181,947. The decrease was primarily attributable to lower interest expense resulting from conversions of outstanding debt balances during 2026 partially offset by higher losses on extinguishment of liabilities recognized in connection with the conversion of debt principal and other payable balances during the period.
Net Loss
For the six months ended June 30, 2026 and 2025 we had a net loss of $955,073 and $1,077,546, respectively.
Liquidity is the ability of an enterprise to generate adequate amounts of cash to meet its needs for cash requirements. As of MarchJune 31,30, 2026, we had $288,858$233,427 in cash and cash equivalents compared to $255,940 at December 31, 2025, ana increasedecrease of $32,918$22,513 resulting primarily from financing activities offset by cash used in our operations. As of MarchJune 31,30, 2026, we had undiscounted obligations in the amount of approximately $1.3$1.1 million relating to the payment of indebtedness due within one year.
As of MarchJune 31,30, 2026, we had a working capital deficiency of $4,720,284$4,875,875 downup from a working capital deficiency of $4,564,798 as of December 31, 2025. At MarchJune 31,30, 2026 our current assets were $331,050$275,619 and consisted almost entirelyprimarily of cash. At MarchJune 31,30, 2026 our current liabilities were $5,051,334$5,151,494 and consisted predominantly of accounts payable and accrued expenses, related party accrued expenses, convertible notes payable, and shares to be issued. We had an accumulated deficit of $13,443,112$13,980,080 as of MarchJune 31,30, 2026, an increase from an accumulated deficit of $13,025,007 as of December 31, 2025. We plan to fund our operations with our cash on hand and additional financing.
Our monthly operating costs averaged approximately $12,000 per month for the three months ended March 31, 2026, excluding capital expenditures. We did not have capital expenditures during the three months ended March 31, 2026. We plan to fund our operations with our cash on hand and additional financing.
Operating activities used net cash of $36,258$83,280 for the threesix months ended MarchJune 31,30, 2026, as compared to using net cash of $28,360$192,918 for the threesix months ended MarchJune 31,30, 2025. For the threesix months ended MarchJune 31,30, 2026, cash used in operating activities was primarily driven by our net loss of $418,105$955,073; offset primarily by non-cash additions of amortization expense,expense theof increase$330,593, amortization of debt discount of $11,027, loss on extinguishment of liabilities of $76,388, and issuance of common stock for services of $50,000 and changes in relatedoperating party accrued expenses, the increase in accrued interest,assets and liabilities including the increase in accounts payable and accrued expenses.expenses of $214,802, the increase in related party accrued expenses of $144,000, the increase in accrued interest $73,008, the decrease in prepaid expenses of $12,500, partially offset by the increase in inventory of $40,525. For the threesix months ended MarchJune 31,30, 2025, cash used in operating activities was primarily driven by our net loss of $591,397$1,077,546; offset primarily by non-cash adjustments for amortization expense,expense of approximately $328,000 and the gain recognized on common stock issued to settle liability of approximately $55,000, and changes in operating assets and liabilities including the increase in related party accrued expenses of approximately $94,000, the increase in accrued interest of approximately $60,038, and the increase in accounts payable and accrued expenses andof theapproximately increase in related party accrued expenses.$344,739.
Investing activities used net cash of $0 for the six months ended June 30, 2026, and 2025.
Investing activities used net cash of $0 for the three months ended March 31, 2026, and 2025. Financing activities produced cash flows of $69,176$60,767 and $0$250,000 for the threesix months ended MarchJune 31,30, 2026, and 2025, respectively. For the threesix months ended MarchJune 31,30, 20262026, financing activities were composed primarily of proceeds from convertible notes payable of $98,000 offset by $28,824$37,233 of the repayment of convertible notes payable. There were no financing cash flows duringFor the threesix months ended MarchJune 31,30, 2025.2025, financing activities were composed primarily of proceeds from convertible notes payable of $250,000.
For the threesix months ended MarchJune 31,30, 2026, the Company incurred a net loss of $418,105,$955,073, had negative cash flows from operations of $36,258$83,280 and may incur additional future losses. At MarchJune 31,30, 2026, the Company had total current assets of $331,050$275,619 and total current liabilities of $5,051,334,$5,151,494, resulting in a working capital deficit of $4,720,284.$4,875,875. These conditions raise substantial doubt about the Company’s ability to continue as a going concern for a period of time within one year after that date that the consolidated financial statements are issued.
We have identified the policies outlined below as critical to our business operations and an understanding of our results of operations. The list is not intended to be a comprehensive list of all of our accounting policies. In many cases, the accounting treatment of a particular transaction is specifically dictated by generally accepted accounting principles in the United States, with no need for management’s judgment in their application. The impact and any associated risks related to these policies on our business operations is discussed throughout Management’s Discussion and Analysis of Financial Condition and Results of Operations when such policies affect our reported and expected financial results. For a detailed discussion on the application of these and other accounting policies, see the notes to our MarchJune 31,30, 2026, financial statements. Note that our preparation of the financial statements requires us to make estimates and assumptions that affect the reported amount of assets and liabilities, disclosure of contingent assets and liabilities at the date of our financial statements, and the reported amounts of revenue and expenses during the reporting period. We cannot assure that actual results will not differ from those estimates.
AIBT insider buying and selling (Form 4)
Since 2026-04-11, insiders reported open-market purchases in 0 Form 4 filings and open-market sales in 0 filings. Totals add up every open-market (code P and S) line in those filings, using the prices reported in the filings. Awards, option exercises, tax withholding and gifts are listed below but not counted.
No Form 4 stock transactions in this period.
Well-known investors holding AIBT (13F)
None of the 59 investors we track reported a position in their latest 13F.